Bionano Genomics

-$0.03 (-1.97%) As of 1:02 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BNGO and other ETFs, options, and stocks.

About BNGO

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics.

CEO
Robert Erik Holmlin
Employees
299
Headquarters
San Diego, California
Founded
2003

BNGO Key Statistics

Market cap
443.24M
Price-Earnings ratio
—
Dividend yield
—
Average volume
6.72M
High today
$1.53
Low today
$1.29
Open price
$1.32
Volume
8.13M
52 Week high
$6.88
52 Week low
$1.16

BNGO Earnings

-$0.11
-$0.07
-$0.04
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure